Literature DB >> 34784038

Production, Isolation, and Characterization of Bioengineered Bacterial Extracellular Membrane Vesicles Derived from Bacteroides thetaiotaomicron and Their Use in Vaccine Development.

Régis Stentz1, Ariadna Miquel-Clopés1, Simon R Carding2.   

Abstract

Bacterial extracellular vesicles (BEVs) possess features that make them well suited for the delivery of therapeutics and vaccines. This chapter describes methods for engineering the commensal human intestinal bacterium Bacteroides thetaiotaomicron (Bt) to produce BEVs carrying vaccine antigens and accompanying methods for isolating and purifying BEVs for mucosal vaccination regimens.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bacterial extracellular vesicles; Bacteroides thetaiotaomicron; Crossflow ultrafiltration; Immunization; Vaccines

Mesh:

Year:  2022        PMID: 34784038     DOI: 10.1007/978-1-0716-1900-1_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

Authors:  David J Chen; Nikolaus Osterrieder; Stephan M Metzger; Elizabeth Buckles; Anne M Doody; Matthew P DeLisa; David Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

2.  Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.

Authors:  Gaurav Kanojia; René H M Raeven; Larissa van der Maas; Tim H E Bindels; Elly van Riet; Bernard Metz; Peter C Soema; Rimko Ten Have; Henderik W Frijlink; Jean-Pierre Amorij; Gideon F A Kersten
Journal:  J Control Release       Date:  2018-07-24       Impact factor: 9.776

Review 3.  COVID-19 vaccine development and a potential nanomaterial path forward.

Authors:  Matthew D Shin; Sourabh Shukla; Young Hun Chung; Veronique Beiss; Soo Khim Chan; Oscar A Ortega-Rivera; David M Wirth; Angela Chen; Markus Sack; Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Nat Nanotechnol       Date:  2020-07-15       Impact factor: 39.213

Review 4.  Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions.

Authors:  Carmen Schwechheimer; Meta J Kuehn
Journal:  Nat Rev Microbiol       Date:  2015-10       Impact factor: 60.633

5.  Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines.

Authors:  Carmen Arigita; Wim Jiskoot; Janny Westdijk; Cor van Ingen; Wim E Hennink; Daan J A Crommelin; Gideon F A Kersten
Journal:  Vaccine       Date:  2004-01-26       Impact factor: 3.641

Review 6.  Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body.

Authors:  Régis Stentz; Ana L Carvalho; Emily J Jones; Simon R Carding
Journal:  Biochem Soc Trans       Date:  2018-08-28       Impact factor: 5.407

Review 7.  Novel approaches for the design, delivery and administration of vaccine technologies.

Authors:  J Wallis; D P Shenton; R C Carlisle
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

8.  Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract.

Authors:  Ana L Carvalho; Sonia Fonseca; Ariadna Miquel-Clopés; Kathryn Cross; Khoon-S Kok; Udo Wegmann; Katherine Gil-Cordoso; Eleanor G Bentley; Sanaria H M Al Katy; Janine L Coombes; Anja Kipar; Regis Stentz; James P Stewart; Simon R Carding
Journal:  J Extracell Vesicles       Date:  2019-06-24

Review 9.  New Vaccine Technologies to Combat Outbreak Situations.

Authors:  Susanne Rauch; Edith Jasny; Kim E Schmidt; Benjamin Petsch
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

Review 10.  Recent Advances in Vaccine Technologies.

Authors:  Michael James Francis
Journal:  Vet Clin North Am Small Anim Pract       Date:  2017-12-06       Impact factor: 2.093

View more
  1 in total

Review 1.  The Mycoplasma spp. 'Releasome': A New Concept for a Long-Known Phenomenon.

Authors:  Patrice Gaurivaud; Florence Tardy
Journal:  Front Microbiol       Date:  2022-04-15       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.